Zoetis Inc
NYSE:ZTS

Watchlist Manager
Zoetis Inc Logo
Zoetis Inc
NYSE:ZTS
Watchlist
Price: 173.96 USD -1.24% Market Closed
Market Cap: 78.8B USD
Have any thoughts about
Zoetis Inc?
Write Note

Relative Value

The Relative Value of one ZTS stock under the Base Case scenario is 148.59 USD. Compared to the current market price of 173.96 USD, Zoetis Inc is Overvalued by 15%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

ZTS Relative Value
Base Case
148.59 USD
Overvaluation 15%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
90
vs Industry
16
Median 3Y
9.6
Median 5Y
10.1
Industry
2.6
Forward
8.4
vs History
90
vs Industry
13
Median 3Y
36.8
Median 5Y
39.5
Industry
23
Forward
29.3
vs History
98
vs Industry
13
Median 3Y
37.6
Median 5Y
37.1
Industry
17.8
vs History
79
vs Industry
11
Median 3Y
63.8
Median 5Y
55.4
Industry
25.4
vs History
93
vs Industry
4
Median 3Y
17.1
Median 5Y
18.5
Industry
2.2
vs History
90
vs Industry
13
Median 3Y
10.1
Median 5Y
10.6
Industry
2.8
Forward
8.9
vs History
90
vs Industry
13
Median 3Y
14.4
Median 5Y
15.3
Industry
5.4
vs History
92
vs Industry
15
Median 3Y
24.1
Median 5Y
25.9
Industry
13.7
Forward
21
vs History
93
vs Industry
16
Median 3Y
27.9
Median 5Y
30.2
Industry
17.2
Forward
23.7
vs History
98
vs Industry
12
Median 3Y
39.7
Median 5Y
38.7
Industry
16.5
vs History
98
vs Industry
9
Median 3Y
56.3
Median 5Y
52.8
Industry
19.3
vs History
84
vs Industry
13
Median 3Y
7.4
Median 5Y
7.6
Industry
2

Multiples Across Competitors

ZTS Competitors Multiples
Zoetis Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Zoetis Inc
NYSE:ZTS
78.6B USD 8.6 32.3 21.7 25
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
777.8B USD 19 92.9 49.9 55.6
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.3T DKK 12.2 34.9 24.3 27.7
US
Johnson & Johnson
NYSE:JNJ
367.4B USD 4.2 25 12.1 15.7
US
Merck & Co Inc
NYSE:MRK
249.6B USD 4 20.5 10.4 12.4
CH
Roche Holding AG
SIX:ROG
209.3B CHF 3.6 18.2 10.2 12.1
CH
Novartis AG
SIX:NOVN
180.7B CHF 4.2 12.7 10 14.9
UK
AstraZeneca PLC
LSE:AZN
154.9B GBP 4 30.7 169 253.3
IE
Endo International PLC
LSE:0Y5F
155B USD 66.9 -53 248.3 622.6
P/E Multiple
Earnings Growth
US
Zoetis Inc
NYSE:ZTS
Average P/E: 33.4
32.3
39%
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
92.9
451%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
DK
Novo Nordisk A/S
CSE:NOVO B
34.9
86%
US
Johnson & Johnson
NYSE:JNJ
25
-22%
US
Merck & Co Inc
NYSE:MRK
20.5
7 336%
CH
Roche Holding AG
SIX:ROG
18.2
32%
CH
Novartis AG
SIX:NOVN
12.7
21%
UK
AstraZeneca PLC
LSE:AZN
30.7
177%
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -53 N/A

See Also

Discover More
Back to Top